Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10

Immunity

Volumn 18, Issue 1, 2003, Pages 155-167

  Martin, Ela ^a   O'Sullivan, Brendan ^a   Low, Pauline ^a   Thomas, Ranjeny ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; INTERLEUKIN 10;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; DENDRITIC CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; T LYMPHOCYTE;

EID: 0037240852     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(02)00503-4     Document Type: Article

References (54)

1. Bouchon A., Facchetti F., Weigand M.A., Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 410:2001;1103-1107. a.
2. Bouchon A., Hernandez-Munain C., Cella M., Colonna M. A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J. Exp. Med. 194:2001;1111-1122. b.
3. Buhlmann J.E., Foy T.M., Aruffo A., Crassi K.M., Ledbetter J.A., Green W.R., Xu J.C., Shultz L.D., Roopesian D., Flavell R.A.et al. In the absence of a CD40 signal, B cells are tolerogenic. Immunity. 2:1995;645-653.
4. Burkly L., Hession C., Ogata L., Reilly C., Marconi L.A., Olson D., Tizard R., Cate R., Lo D. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature. 373:1995;531-536.
5. Caamano J., Alexander J., Craig L., Bravo R., Hunter C.A. The NF-kappa B family member RelB is required for innate and adaptive immunity to Toxoplasma gondii. J. Immunol. 163:1999;4453-4461.
6. Cella M., Scheidegger D., Palmer Lehmann K., Lane P., Lanzavecchia A., Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity. T-T help via APC activation J. Exp. Med. 184:1996;747-752.
7. Cobbold S., Waldmann H. Infectious tolerance. Curr. Opin. Immunol. 10:1998;518-524.
8. de Jong E.C., Vieira P.L., Kalinski P., Kapsenberg M.L. Corticosteroids inhibit the production of inflammatory mediators in immature monocyte-derived DC and induce the development of tolerogenic DC3. J. Leukoc. Biol. 66:1999;201-204.
9. Dhodapkar M.V., Steinman R.M., Krasovsky J., Munz C., Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193:2001;233-238.
10. Diehl L., Den Boer A.T., van der Voort E.I., Melief C.J., Offringa R., Toes R.E. The role of CD40 in peripheral T cell tolerance and immunity. J. Mol. Med. 78:2000;363-371.
11. Feldmann M. Pathogenesis of arthritis. recent research progress Nat. Immunol. 2:2001;771-773.
12. Gao J.X., Madrenas J., Zeng W., Cameron M.J., Zhang Z., Wang J.J., Zhong R., Grant D. CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection. Immunology. 98:1999;159-170.
13. Giannoukakis N., Bonham C.A., Qian S., Zhou Z., Peng L., Harnaha J., Li W., Thomson A.W., Fung J.J., Robbins P.D., Lu L. Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides. Mol. Ther. 1:2000;430-437.
14. Gregori S., Casorati M., Amuchastegui S., Smiroldo S., Davalli A.M., Adorini L. Regulatory T cells induced by 1alpha,25-dihydroxyvitamin d(3) and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol. 167:2001;1945-1953.
15. Griffin M.D., Lutz W., Phan V.A., Bachman L.A., McKean D.J., Kumar R. Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs. a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo Proc. Natl. Acad. Sci. USA. 98:2001;6800-6805.
16. Groux H., O'Garra A., Bigler M., Rouleau M., Antonenko S., de Vries J.E., Roncarolo M.G. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 389:1997;737-742.
17. Grumont R., Hochrein H., O'Keeffe M., Gugasyan R., White C., Caminschi I., Cook W., Gerondakis S. c-Rel regulates interleukin 12 p70 expression in CD8(+) dendritic cells by specifically inducing p35 gene transcription. J. Exp. Med. 194:2001;1021-1032.
18. Hackstein H., Morelli A.E., Larregina A.T., Ganster R.W., Papworth G.D., Logar A.J., Watkins S.C., Falo L.D., Thomson A.W. Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells. J. Immunol. 166:2001;7053-7062.
19. Hanninen A., Martinez N.R., Davey G.M., Heath W.R., Harrison L.C. Transient blockade of CD40 ligand dissociates pathogenic from protective mucosal immunity. J. Clin. Invest. 109:2002;261-267.
20. Hofer S., Rescigno M., Granucci F., Citterio S., Francolini M., Ricciardi-Castagnoli P. Differential activation of NF-kappa B subunits in dendritic cells in response to Gram-negative bacteria and to lipopolysaccharide. Microbes Infect. 3:2001;259-265.
21. Hollander G.A., Castigli E., Kulbacki R., Su M., Burakoff S.J., Gutierrez-Ramos J.C., Geha R.S. Induction of alloantigen-specific tolerance by B cells from CD40-deficient mice. Proc. Natl. Acad. Sci. USA. 93:1996;4994-4998.
22. Huang F.P., Platt N., Wykes M., Major J.R., Powell T.J., Jenkins C.D., MacPherson G.G. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 191:2000;435-444.
23. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192:2000;1213-1222.
24. Kawabe T., Naka T., Yoshida K., Tanaka T., Fujiwara H., Suematsu S., Yoshida N., Kishimoto T., Kikutani H. The immune responses in CD40-deficient mice. impaired immunoglobulin class switching and germinal center formation Immunity. 1:1994;167-178.
25. Kumanogoh A., Wang X., Lee I., Watanabe C., Kamanaka M., Shi W., Yoshida K., Sato T., Habu S., Itoh M.et al. Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions. a role of CD40 in regulatory T cell development J. Immunol. 166:2001;353-360.
26. Lawlor K.E., Campbell I.K., O'Donnell K., Wu L., Wicks I.P. Molecular and cellular mediators of interleukin-1-dependent acute inflammatory arthritis. Arthritis Rheum. 44:2001;442-450.
27. Lee J.I., Ganster R.W., Geller D.A., Burckart G.J., Thomson A.W., Lu L. Cyclosporine A inhibits the expression of costimulatory molecules on in vitro-generated dendritic cells. association with reduced nuclear translocation of nuclear factor kappa B Transplantation. 68:1999;1255-1263.
28. Lutz M.B., Suri R.M., Niimi M., Ogilvie A.L., Kukutsch N.A., Rossner S., Schuler G., Austyn J.M. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur. J. Immunol. 30:2000;1813-1822.
29. MacDonald A.S., Patton E.A., La Flamme A.C., Araujo M.I., Huxtable C.R., Bauman B., Pearce E.J. Impaired Th2 development and increased mortality during Schistosoma mansoni infection in the absence of CD40/CD154 interaction. J. Immunol. 168:2002;4643-4649. a.
30. MacDonald A.S., Straw A.D., Dalton N.M., Pearce E.J. Cutting edge. Th2 response induction by dendritic cells; a role for CD40 J. Immunol. 168:2002;537-540. b.
31. Maloy K.J., Powrie F. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2:2001;816-822.
32. Mehling A., Grabbe S., Voskort M., Schwarz T., Luger T.A., Beissert S. Mycophenolate mofetil impairs the maturation and function of murine dendritic cells. J. Immunol. 165:2000;2374-2381.
33. Neumann M., Fries H., Scheicher C., Keikavoussi P., Kolb-Maurer A., Brocker E., Serfling E., Kampgen E. Differential expression of Rel/NF-kappaB and octamer factors is a hallmark of the generation and maturation of dendritic cells. Blood. 95:2000;277-285.
34. O'Sullivan B.J., Thomas R. CD40 Ligation conditions dendritic cell antigen-presenting function through sustained activation of NF-kappaB. J. Immunol. 168:2002;5491-5498.
35. O'Sullivan B.J., MacDonald K.P., Pettit A.R., Thomas R. RelB nuclear translocation regulates B cell MHC molecule, CD40 expression, and antigen-presenting cell function. Proc. Natl. Acad. Sci. USA. 97:2000;11421-11426.
36. Ouaaz F., Arron J., Zheng Y., Choi Y., Beg A.A. Dendritic cell development and survival require distinct NF-κB subunits. Immunity. 16:2002;257-270.
37. Ozaki M.E., Coren B.A., Huynh T.N., Redondo D.J., Kikutani H., Webb S.R. CD4+ T cell responses to CD40-deficient APCs. defects in proliferation and negative selection apply only with B cells as APCs J. Immunol. 163:1999;5250-5256.
38. Pai S., O'Sullivan B.J., Cooper L., Thomas R., Khanna R. RelB nuclear translocation mediated by C-terminal activator regions of Epstein-Barr virus-encoded latent membrane protein 1 and its effect on antigen-presenting function in B cells. J. Virol. 76:2002;1914-1921.
39. Pettit A.R., Quinn C., MacDonald K.P., Cavanagh L.L., Thomas G., Townsend W., Handel M., Thomas R. Nuclear localization of RelB is associated with effective antigen-presenting cell function. J. Immunol. 159:1997;3681-3691.
40. Pettit A.R., MacDonald K.P.A., O'Sullivan B., Thomas R. Differentiated dendritic cells expressing nuclear RelB are predominantly located in rheumatoid synovial tissue perivascular mononuclear cell aggregates. Arthritis Rheum. 43:2000;791-800.
41. Pierce J.W., Schoenleber R., Jesmok G., Best J., Moore S.A., Collins T., Gerritsen M.E. Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol. Chem. 272:1997;21096-21103.
42. Rescigno M., Martino M., Sutherland C.L., Gold M.R., Ricciardi-Castagnoli P. Dendritic cell survival and maturation are regulated by different signaling pathways. J. Exp. Med. 188:1998;2175-2180.
43. + T-helper and T-killer cell. Nature. 393:1998;474-478.
44. Sander B., Andersson J., Andersson U. Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure. Immunol. Rev. 119:1991;65-93.
45. Schulz O., Edwards D.A., Schito M., Aliberti J., Manickasingham S., Sher A., Reis e Sousa C. CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity. 13:2000;453-462.
46. Sha W.C., Liou H.C., Tuomanen E.I., Baltimore D. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell. 80:1995;321-330.
47. Steinbrink K., Wolfl M., Jonuleit H., Knop J., Enk A. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159:1997;4772-4780.
48. Subauste C.S., Wessendarp M., Sorensen R.U., Leiva L.E. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii. patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer J. Immunol. 162:1999;6690-6700.
49. Thompson A.G., Pettit A.R., Padmanabha J., Mansfield H., Frazer I.H., Strutton G.M., Thomas R. Nuclear RelB+ cells are found in normal lymphoid organs and in peripheral tissue in the context of inflammation, but not under normal resting conditions. Immunol. Cell Biol. 80:2002;164-169.
50. Weih F., Carrasco D., Durham S.K., Barton D.S., Rizzo C.A., Ryseck R.P., Lira S.A., Bravo R. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell. 80:1995;331-340.
51. Weih F., Warr G., Yang H., Bravo R. Multifocal defects in immune responses in RelB-deficient mice. J. Immunol. 158:1997;5211-5218.
52. Wu L., D'Amico A., Winkel K.D., Suter M., Lo D., Shortman K. RelB is essential for the development of myeloid-related CD8α- dendritic cells but not of lymphoid-related CD8α+ dendritic cells. Immunity. 9:1998;839-847.
53. Yoshimura S., Bondeson J., Foxwell B.M., Brennan F.M., Feldmann M. Effective antigen presentation by dendritic cells in NF-kappaB dependent coordinate regulation of MHC, costimulatory molecules and cytokines. Int. Immunol. 13:2001;675-683.
54. Zhou P., Seder R.A. CD40 ligand is not essential for induction of type 1 cytokine responses or protective immunity after primary or secondary infection with histoplasma capsulatum. J. Exp. Med. 187:1998;1315-1324.